Quantcast
Environmental News for a Healthier Planet and Life

Bayer Monsanto Damages Reduced to $25.27 Million by U.S. Judge

Health + Wellness
The compound of German chemicals and pharmaceuticals giant Bayer in Berlin. ODD ANDERSEN / AFP / Getty Images

U.S. District Judge Vince Chhabria announced his ruling in San Francisco on Monday.


Chhabria reduced the amount that Germany's Bayer AG has to pay the claimant to $25.27 million (€22.4 million). Bayer bought Roundup maker Monsanto for $63 billion last year.

Following a four-week trial in March a federal jury awarded $5 million (€4.4 million) in compensatory and $75 million in punitive damages to a man who blamed his cancer on glyphosate-based weed killer Roundup.

Edwin Hardeman was diagnosed with non-Hodgkin's lymphoma in 2014.

Limits on Ratios for Damages

At a hearing to discuss Bayer's request to overturn the verdict earlier this month, Chhabria said, "It's quite clear that under the Constitution I'm required to reduce the punitive damages award and it's just a question of how much."

U.S. Supreme Court rulings limit the ratio of punitive to compensatory damages to 9 to 1.

The judge said he would also take into account the fact that Hardeman was now in full remission and unlikely to suffer as much as he had in the past.

Bayer says Roundup — and its active ingredient glyphosate — are safe for human use and not carcinogenic. However, in 2015 the World Health Organization's cancer arm reached a different conclusion, classifying glyphosate as "probably carcinogenic to humans."

Roundup products for sale in California.


Litigation Hits Share Price

The Leverkusen-based company is facing lawsuits from more than 13,400 plaintiffs in the U.S.

Earlier this year, Bayer CEO Werner Baumann conceded the effect the court cases had had on the share price: "We have lost two cases in lower courts. That is why the company is massively affected. You see it in our share price," he said at an academic business event in Cologne in April. "You see it selectively, mainly here in Germany and in France — less so in the USA — in our reputational scores."

Over the past year, Bayer's share price has dropped dramatically and the company has seen €30 billion (approximately $33.7 billion) wiped off its market value since the first court ruling last August. Its share price has fallen from €96 (approximately $108) in August 2018 to €58.63 (approximately $66) at close of markets in Frankfurt on Monday.

Reposted with permission from our media associate DW.

EcoWatch Daily Newsletter

An aerial view of a crude oil storage facility of Caspian Pipeline Consortium (CPC) in the Krasnodar Territory. Vitaly Timkiv / TASS / Getty Images

Oil rigs around the world keep pulling crude oil out of the ground, but the global pandemic has sent shockwaves into the market. The supply is up, but demand has plummeted now that industry has ground to a halt, highways are empty, and airplanes are parked in hangars.

Read More Show Less
Examples (from left) of a lead pipe, a corroded steel pipe and a lead pipe treated with protective orthophosphate. U.S. EPA Region 5

Under an agreement negotiated by community groups — represented by NRDC and the Pennsylvania Utility Law Project — the Pittsburgh Water and Sewer Authority (PWSA) will remove thousands of lead water pipes by 2026 in order to address the chronically high lead levels in the city's drinking water and protect residents' health.

Read More Show Less
Sponsored
ROBYN BECK / AFP / Getty Images

By Dave Cooke

So, they finally went and did it — the Trump administration just finalized a rule to undo requirements on manufacturers to improve fuel economy and reduce greenhouse gas emissions from new passenger cars and trucks. Even with the economy at the brink of a recession, they went forward with a policy they know is bad for consumers — their own analysis shows that American drivers are going to spend hundreds of dollars more in fuel as a result of this stupid policy — but they went ahead and did it anyway.

Read More Show Less

By Richard Connor

A blood test that screens for more than 50 types of cancer could help doctors treat patients at an earlier stage than previously possible, a new study shows. The method was used to screen for more than 50 types of cancer — including particularly deadly variants such as pancreatic, ovarian, bowel and brain.

Read More Show Less
Ian Sane / Flickr

Preliminary data from the Centers for Disease Control showed a larger number of young people coming down with COVID-19 than first expected, with patients under the age of 45 comprising more than a third of all cases, and one in five of those patients requiring hospitalization. That also tends to be the group most likely to use e-cigarettes.

Read More Show Less